Peter is the President of SHA, a consulting firm to the Pharmaceutical Industry. He currently serves as Interim Division President for Qualitest Generics and has assisted Endo Pharmaceuticals in their recent restructuring program. He has provided Management consulting to a number of other Pharmaceutical clients. Previously he served as President for North America Commercial Operations for Patheon Pharmaceuticals and also held the role of Interim CEO of Patheon. Patheon is a leading Contract Manufacturing and Contract Research Organization serving the Pharmaceutical Industry with $700 million in Revenue and 4700 employees. Prior to joining Patheon, Peter spent 14 years with Wyeth Pharmaceuticals. From 2003 to 2009 he was responsible for supply of Wyeth’s Consumer Healthcare products globally. The consumer supply network consisted of six manufacturing sites, external suppliers, technical support functions and supply chain. Wyeth Consumer Healthcare (now Pfizer Consumer Healthcare) included such well known brands as Advil, Centrum Vitamins, Chapstick and Robitussin. From 1995 to 2003 he served in a variety of senior Engineering and Operations roles for the Prescription Drug side of the Wyeth business. Peter also spent 14 years at SmithKline Beecham (now GlaxoSmithKline) before joining Wyeth. His assignments included significant international project work in Europe and the Far East and operations experience with injectable product manufacturing. Peter is a member of the International Leadership Forum of the ISPE and is a frequent speaker at Industry events. He has a BS in Mechanical Engineering from Villanova University and an MBA from Philadelphia University. Peter and his wife Lynn and their two children reside in Valley Forge, Pennsylvania.